je.st
news
Tag: merck
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
2013-02-14 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities class-action lawsuits. The suits are pending in the U.S. District Court for the District of New Jersey against Merck, Schering-Plough Corporation and certain of their current and former officers and directors. Language: English Contact HTML: MerckMedia Contacts:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461ORInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: related
trial
enhance
securities
Merck Statement on Venezuelan Currency Devaluation
2013-02-13 15:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, said today that it has completed a preliminary assessment of the impact of the Venezuelan governments intention to devalue its currency effective Feb. 13, 2013. Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461Investor:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: statement
currency
merck
venezuelan
Merck to Present at the Leerink Swann 2013 Global Healthcare Conference
2013-02-12 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Leerink Swann 2013 Global Healthcare Conference in New York on February 13 at 11:30 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449Investors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: present
global
conference
healthcare
Analyst downgrades Merck over two drugs
2013-02-04 22:18:25| Biotech - Topix.net
Shares of drugmaker Merck & Co. declined after an analyst downgraded them from "Buy" to "Sell." Morgan Stanley & Co.
Tags: drugs
analyst
merck
downgrades
Generic competition, charges cut Merck Q4 profit
2013-02-01 15:00:12| Biotech - Topix.net
Merck & Co.'s fourth-quarter profit fell 7% as generic competition slashed sales of its blockbuster allergy drug Singulair and the drugmaker took sizeable restructuring and acquisition charges.
Tags: cut
charges
profit
competition
Sites : [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] next »